DAV

Disabled American Veterans

DESI

drug efficacy study implementation

DOD

Department of Defense

DUR

drug utilization review

FDA

Food and Drug Administration

FSS

Federal Supply Schedule

GAO

General Accounting Office

H2R

histamine2 receptor

5-HT3

5-hydroxytryptamine

HCFA

Health Care Financing Administration

HCTZ

hydrochlorothiazide

HMG-CoA RI

hydroxymethylglutaryl-coenzyme A reductase inhibitor

HMO

health maintenance organization

ICD-9

International Classification of Diseases, Ninth Edition

IOM

Institute of Medicine

IPA

Independent practice association

IV

intravenous

JCAH, JCAHO

Joint Commission on Accreditation of Hospitals, now Joint Commission on Accreditation of Healthcare Organizations

MAP

Medical Advisory Panel

MCO

managed care organization

MTF

military treatment facility

NAC

National Acquisition Center

NCQA

National Committee for Quality Assurance

NDAA

National Defense Authorization Act

NPC

National Pharmaceutical Council

NRC

National Research Council

NSAID

nonsteroidal anti-inflammatory drug

OBRA

Omnibus Budget Reconciliation Act

OTC

over the counter

1P

FDA priority (drug)

P&T

pharmacy and therapeutics

PBM

pharmacy benefits management organization

PVA

Paralyzed Veterans of America

RFP

request for proposal



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement